Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Eldhagen

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
European Journal of Heart Failure|September 6, 2022
Diagnosing heart failure with preserved ejection fraction in cardiac amyloidosis or diagnosing cardiac amyloidosis in heart failure with preserved ejection fraction?Lars H Lund, Per Eldhagen
Journal of Clinical Medicine|July 27, 2022
RWT/SaVR-A Simple and Highly Accurate Measure Screening for Transthyretin Cardiac AmyloidosisElsa Arnberg, Per Eldhagen, Viktor Löfbacka, et al.
Annals of Medicine|December 14, 2023
Health care resource use, diagnostic delay and disease burden in transthyretin amyloid cardiomyopathy in SwedenFrida Hjalte, Jenny M Norlin, Linda Alverbäck-Labberton, et al.
Lakartidningen|April 22, 2021
Erik Linnér, Björn Pilebro, Per Eldhagen, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 26, 2025
Cardiac amyloidosis after lumbar spinal stenosis surgery - a comprehensive prospective cohort studyPer Eldhagen, Antonios Tzortzakakis, Lars H Lund, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 3, 2026
Efficacy of diflunisal for hereditary transthyretin amyloidosis: the Swedish real-world experienceJohn L Berk, Kevin J Carroll, Jorge Mejia Baranda, et al.
Journal of Internal Medicine|September 17, 2025
Sixty years of experience with hereditary transthyretin amyloidosis: Insights from the Swedish transthyretin amyloidosis registryLotta Stenberg, Björn Pilebro, Intissar Anan, et al.
Orphanet Journal of Rare Diseases|July 27, 2025
Introducing a revised version of the Kumamoto scale as an easy-to-use clinical tool for monitoring multisystemic changes in hereditary transthyretin amyloidosisJonas Wixner, Björn Pilebro, Tale N Wien, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|February 26, 2026
Lysozyme as an amyloid fibril protein together with transthyretin in the ligamentum flavum in association with lumbar spinal stenosisGunilla Westermark, Svante Berg, Per Eldhagen, et al.
Open Heart|February 24, 2026
Diagnostic delay and phenotypic differences in cardiac sarcoidosis: a descriptive study of diagnostic and follow-up clinical dataSusanna Kullberg, Jonas Faxén, Julia Cagan, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
European Journal of Heart Failure|September 6, 2022
Diagnosing heart failure with preserved ejection fraction in cardiac amyloidosis or diagnosing cardiac amyloidosis in heart failure with preserved ejection fraction?Lars H Lund, Per Eldhagen
Journal of Clinical Medicine|July 27, 2022
RWT/SaVR-A Simple and Highly Accurate Measure Screening for Transthyretin Cardiac AmyloidosisElsa Arnberg, Per Eldhagen, Viktor Löfbacka, et al.
Annals of Medicine|December 14, 2023
Health care resource use, diagnostic delay and disease burden in transthyretin amyloid cardiomyopathy in SwedenFrida Hjalte, Jenny M Norlin, Linda Alverbäck-Labberton, et al.
Lakartidningen|April 22, 2021
Erik Linnér, Björn Pilebro, Per Eldhagen, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 26, 2025
Cardiac amyloidosis after lumbar spinal stenosis surgery - a comprehensive prospective cohort studyPer Eldhagen, Antonios Tzortzakakis, Lars H Lund, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 3, 2026
Efficacy of diflunisal for hereditary transthyretin amyloidosis: the Swedish real-world experienceJohn L Berk, Kevin J Carroll, Jorge Mejia Baranda, et al.
Journal of Internal Medicine|September 17, 2025
Sixty years of experience with hereditary transthyretin amyloidosis: Insights from the Swedish transthyretin amyloidosis registryLotta Stenberg, Björn Pilebro, Intissar Anan, et al.
Orphanet Journal of Rare Diseases|July 27, 2025
Introducing a revised version of the Kumamoto scale as an easy-to-use clinical tool for monitoring multisystemic changes in hereditary transthyretin amyloidosisJonas Wixner, Björn Pilebro, Tale N Wien, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|February 26, 2026
Lysozyme as an amyloid fibril protein together with transthyretin in the ligamentum flavum in association with lumbar spinal stenosisGunilla Westermark, Svante Berg, Per Eldhagen, et al.
Open Heart|February 24, 2026
Diagnostic delay and phenotypic differences in cardiac sarcoidosis: a descriptive study of diagnostic and follow-up clinical dataSusanna Kullberg, Jonas Faxén, Julia Cagan, et al.
Pageof 2